X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9761) 9761
Book Review (2307) 2307
Publication (881) 881
Book Chapter (77) 77
Conference Proceeding (27) 27
Magazine Article (20) 20
Book / eBook (13) 13
Dissertation (7) 7
Web Resource (5) 5
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8660) 8660
humans (6295) 6295
male (5042) 5042
animals (3865) 3865
phosphodiesterase inhibitors - therapeutic use (2599) 2599
pharmacology & pharmacy (2177) 2177
sildenafil citrate (1891) 1891
female (1850) 1850
middle aged (1801) 1801
phosphodiesterase inhibitors - pharmacology (1770) 1770
sildenafil (1602) 1602
erectile dysfunction - drug therapy (1593) 1593
rats (1526) 1526
erectile dysfunction (1519) 1519
adult (1371) 1371
phosphodiesterase (1327) 1327
piperazines - therapeutic use (1324) 1324
phosphodiesterase 5 inhibitors - therapeutic use (1269) 1269
aged (1250) 1250
urology & nephrology (1209) 1209
treatment outcome (1194) 1194
mice (1135) 1135
impotence (909) 909
tadalafil (887) 887
analysis (847) 847
abridged index medicus (820) 820
purines (802) 802
dose-response relationship, drug (785) 785
sulfones (774) 774
phosphodiesterase inhibitors (699) 699
double-blind (694) 694
sulfones - therapeutic use (681) 681
neurosciences (671) 671
drug therapy (663) 663
nitric oxide (651) 651
disease models, animal (647) 647
care and treatment (645) 645
cardiac & cardiovascular systems (643) 643
hypertension, pulmonary - drug therapy (639) 639
nitric-oxide (607) 607
research (605) 605
men (597) 597
cyclic amp - metabolism (586) 586
expression (575) 575
rats, sprague-dawley (566) 566
health aspects (547) 547
double-blind method (541) 541
phosphodiesterase inhibitors - administration & dosage (541) 541
inflammation (540) 540
3',5'-cyclic-amp phosphodiesterases - antagonists & inhibitors (531) 531
vasodilator agents - therapeutic use (530) 530
therapy (528) 528
biochemistry & molecular biology (524) 524
purines - therapeutic use (524) 524
phosphodiesterase inhibitors - adverse effects (522) 522
piperazines - pharmacology (518) 518
pulmonary hypertension (513) 513
camp (512) 512
respiratory system (512) 512
risk factors (495) 495
drug therapy, combination (485) 485
efficacy (483) 483
inhibitors (477) 477
time factors (477) 477
erectile dysfunction - etiology (473) 473
rodents (473) 473
medicine & public health (468) 468
hypertension (467) 467
cyclic gmp - metabolism (463) 463
article (459) 459
phosphoric diester hydrolases - metabolism (448) 448
rats, wistar (440) 440
rolipram (431) 431
cell biology (428) 428
inhibition (426) 426
phosphodiesterases (417) 417
carbolines - therapeutic use (413) 413
in vitro techniques (413) 413
apoptosis (403) 403
enzymes (401) 401
phosphodiesterase inhibitor (400) 400
in-vitro (395) 395
cyclic nucleotide phosphodiesterases, type 5 (394) 394
proteins (391) 391
3',5'-cyclic-gmp phosphodiesterases - antagonists & inhibitors (389) 389
vardenafil dihydrochloride (389) 389
safety (386) 386
phosphodiesterase 5 inhibitors (384) 384
administration, oral (383) 383
activation (382) 382
cells (377) 377
medicine (377) 377
medicine, general & internal (377) 377
physiology (376) 376
physiological aspects (375) 375
cyclic nucleotide phosphodiesterases, type 4 (374) 374
signal transduction (365) 365
cells, cultured (364) 364
vardenafil (363) 363
phosphodiesterase 5 inhibitors - pharmacology (360) 360
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9453) 9453
German (118) 118
French (64) 64
Chinese (57) 57
Russian (56) 56
Japanese (35) 35
Spanish (25) 25
Portuguese (8) 8
Dutch (6) 6
Italian (6) 6
Polish (5) 5
Turkish (3) 3
Bulgarian (2) 2
Czech (2) 2
Hebrew (2) 2
Hungarian (2) 2
Danish (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2017, Volume 76, Issue 8, pp. 1327 - 1339
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new... 
Systemic Sclerosis | Cyclophosphamide | Treatment | Methotrexate | ORAL PROSTACYCLIN ANALOG | SCLERODERMA RENAL CRISIS | DIGITAL ULCERS | DOUBLE-BLIND TRIAL | PULMONARY ARTERIAL-HYPERTENSION | INTESTINAL BACTERIAL OVERGROWTH | INTRAVENOUS EPOPROSTENOL | RAYNAUDS-PHENOMENON SECONDARY | STANDARDIZED OPERATING PROCEDURES | RHEUMATOLOGY | STEM-CELL TRANSPLANTATION | Glucocorticoids - therapeutic use | Pyrazoles - therapeutic use | Humans | Gastrointestinal Diseases - etiology | Lung Diseases - therapy | Raynaud Disease - etiology | Hypertension, Pulmonary - therapy | Lung Diseases - etiology | Scleroderma, Systemic - therapy | Delphi Technique | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Raynaud Disease - therapy | Fingers | Scleroderma, Systemic - complications | Phosphodiesterase 5 Inhibitors - therapeutic use | Fluoxetine - therapeutic use | Ulcer - etiology | Ulcer - therapy | Europe | Rheumatology | Serotonin Uptake Inhibitors - therapeutic use | Hematopoietic Stem Cell Transplantation | Gastrointestinal Diseases - therapy | Prostaglandins I - therapeutic use | Pyrimidines - therapeutic use | Kidney Diseases - therapy | Kidney Diseases - etiology | Endothelin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Endothelin | Experts | Fluoxetine | Lung diseases | Clinical trials | Stem cell transplantation | Transplantation | Prostacyclin | Patients | Sclerosis | Literature reviews | Studies | Systemic sclerosis | Ulcers | Skin diseases | Scleroderma | Phosphodiesterase | Kidney transplantation | Index Medicus | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Reumatologi och inflammation
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 11/2018, Volume 70, Issue 11, pp. 1820 - 1828
ObjectiveMethodsThere is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc... 
MORTALITY | VARIABILITY | SCLERODERMA | METAANALYSIS | MANAGEMENT | DIGITAL ULCERS | DISEASE | COHORT | RHEUMATOLOGY | Lung Diseases, Interstitial - etiology | Glucocorticoids - therapeutic use | Raynaud Disease - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Raynaud Disease - etiology | Methotrexate - therapeutic use | Calcium Channels - therapeutic use | Cyclophosphamide - therapeutic use | Rituximab - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Scleroderma, Systemic - complications | Arthritis - etiology | Hypertension, Pulmonary - drug therapy | Phosphodiesterase 5 Inhibitors - therapeutic use | Antirheumatic Agents - therapeutic use | Prostaglandins - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Kidney Diseases - drug therapy | Lung Diseases, Interstitial - drug therapy | Algorithms | Hydroxychloroquine | Mycophenolic Acid - therapeutic use | Arthritis - drug therapy | Kidney Diseases - etiology | Endothelin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Scleroderma, Systemic - drug therapy | Mycophenolic acid | Intravenous administration | Endothelin | Glucocorticoids | Calcium | Medical services | Clinical trials | Stem cell transplantation | Transplantation | Arthritis | Sclerosis | Consortia | Prostaglandins | Enzyme inhibitors | Methotrexate | Scleroderma | Phosphodiesterase | Hypertension | Medical research | Lung diseases | Rituximab | Inflammation | Switching | Hemopoiesis | Cyclophosphamide | Inhibitors | Systemic sclerosis | Ulcers | Stem cells | Angiotensin | Skin | Mycophenolate mofetil
Journal Article
JAMA, ISSN 0098-7484, 03/2013, Volume 309, Issue 12, pp. 1268 - 1277
Journal Article
The Prostate, ISSN 0270-4137, 09/2013, Volume 73, Issue 13, pp. 1391 - 1402
BACKGROUND. Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH)/low urinary tract symptoms (LUTS) are often comorbid. Chronic inflammation is one... 
metabolic syndrome | lipids | tadalafil | PDE5 inhibitors | inflammation | BPH/LUTS | prostate | vardenafil | SPONTANEOUSLY HYPERTENSIVE-RATS | TESTOSTERONE | MODEL | ANDROGEN RECEPTOR ACTIVATION | BENIGN PROSTATIC HYPERPLASIA | URINARY-TRACT SYMPTOMS | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | OXYTOCIN RECEPTOR | BLADDER | CGMP-MEDIATED INHIBITION | Cyclic GMP - pharmacology | Inflammation - pathology | Sulfones - therapeutic use | Prostatic Hyperplasia - pathology | Triazines - therapeutic use | Lower Urinary Tract Symptoms - pathology | Humans | Middle Aged | Male | Sulfones - pharmacology | Prostate - metabolism | Myofibroblasts - metabolism | Prostate - pathology | Inflammation - metabolism | Cyclic GMP - analogs & derivatives | Lower Urinary Tract Symptoms - drug therapy | Inflammation - drug therapy | Aged, 80 and over | Prostate - drug effects | Interleukin-8 - secretion | Phosphodiesterase 5 Inhibitors - therapeutic use | Imidazoles - therapeutic use | Phosphodiesterase 5 Inhibitors - pharmacology | Carbolines - therapeutic use | Prostatic Hyperplasia - drug therapy | Myofibroblasts - pathology | Triazines - pharmacology | Double-Blind Method | Treatment Outcome | Imidazoles - pharmacology | Piperazines - therapeutic use | Myofibroblasts - drug effects | Piperazines - pharmacology | Prostatic Hyperplasia - metabolism | Tadalafil | Pilot Projects | Lower Urinary Tract Symptoms - metabolism | Vardenafil Dihydrochloride | Aged | Carbolines - pharmacology | Low density lipoproteins | Inflammation | Cholesterol | Index Medicus
Journal Article
Journal Article
Journal Article
FASEB Journal, ISSN 0892-6638, 2017, Volume 31, Issue 12, pp. 5307 - 5320
Duchenne muscular dystrophy (DMD) is the most common inherited muscular dystrophy. Patients experience DMD in their 20s from cardiac or respiratory failure... 
Muscle fibrosis | DMD | Sildenafil | Piclamilast | FIBROSIS | RESVERATROL | CELLS | TGF-BETA | muscle fibrosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUSCLE | piclamilast | sildenafil | CELL BIOLOGY | MOUSE MODEL | BIOLOGY | NITRIC-OXIDE | OXIDE SYNTHASE TRANSGENE | EXPRESSION | Fibrosis - drug therapy | Muscular Dystrophy, Animal - drug therapy | Sildenafil Citrate - therapeutic use | Male | Muscle, Skeletal - metabolism | Fibrosis - metabolism | Benzamides - therapeutic use | Muscle, Skeletal - drug effects | Mice, Inbred mdx | Muscular Dystrophy, Animal - metabolism | Anti-Inflammatory Agents - therapeutic use | Phosphodiesterase 5 Inhibitors - therapeutic use | PPAR gamma - genetics | Pyridines - therapeutic use | Fibrosis - enzymology | Muscular Dystrophy, Duchenne - drug therapy | Mice, Inbred C57BL | RNA, Messenger - genetics | Muscular Dystrophy, Duchenne - enzymology | Phosphodiesterase 4 Inhibitors - therapeutic use | Animals | Muscular Dystrophy, Animal - enzymology | Muscle Contraction - drug effects | Mice | Muscular Dystrophy, Duchenne - metabolism | Therapy | Animal models | Cardiac muscle | Therapeutic applications | Muscles | Phosphodiesterase IV | Pharmacology | Inflammation | mRNA | Chemical compounds | Muscular dystrophy | Inhibitors | Ischemia | Rodents | Collagen | Duchenne's muscular dystrophy | Fibrosis | Diaphragm (anatomy) | Dystrophy | Diaphragm | Heart diseases | Phosphodiesterase | Index Medicus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2017, Volume 50, Issue 3, pp. 1602425 - 1602425
Journal Article